Search Results - Berten Ceulemans
- Showing 1 - 20 results of 50
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Low‐dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients by An‐Sofie Schoonjans, Bernard P. Paelinck, Fabienne Marchau, Boudewijn Gunning, Arnold R. Gammaitoni, Bradley S. Galer, Lieven Lagae, Berten Ceulemans
Published 2016Artigo -
9
Cardiovascular safety of low-dose fenfluramine in Dravet syndrome: a review of its benefit-risk profile in a new patient population by An‐Sofie Schoonjans, Fabienne Marchau, Bernard P. Paelinck, Lieven Lagae, Arnold R. Gammaitoni, Milka Pringsheim, Martin Keane, Berten Ceulemans
Published 2017Revisão -
10
-
11
-
12
Pharmacological Characterization of an Antisense Knockdown Zebrafish Model of Dravet Syndrome: Inhibition of Epileptic Seizures by the Serotonin Agonist Fenfluramine by Yifan Zhang, Angéla Kecskés, Daniëlle Copmans, Mélanie Langlois, Alexander D. Crawford, Berten Ceulemans, Lieven Lagae, Peter de Witte, Camila V. Esguerra
Published 2015Artigo -
13
Treatment and long term outcome in West syndrome: The clinical reality. A multicentre follow up study by Lieven Lagae, Hélène Verhelst, Berten Ceulemans, Linda De Meırleır, Marie‐Cécile Nassogne, V. de Borchgrave, Marc D’Hooghe, Martine Foulon, Patrick Van Bogaert
Published 2010Artigo -
14
Subtelomeric deletions detected in patients with idiopathic mental retardation using multiplex ligation-dependent probe amplification (MLPA) by Liesbeth Rooms, Edwin Reyniers, Rob van Luijk, Stefaan Scheers, J. Wauters, Berten Ceulemans, Jenneke van den Ende, Yolande van Bever, R. Frank Kooy
Published 2003Artigo -
15
-
16
Accelerometry-Based Home Monitoring for Detection of Nocturnal Hypermotor Seizures Based on Novelty Detection by Kris Cuppens, Peter Karsmakers, Anouk Van de Vel, Bert Bonroy, Milica Milošević, Stijn Luca, Tom Croonenborghs, Berten Ceulemans, Lieven Lagae, Sabine Van Huffel, Bart Vanrumste
Published 2013Artigo -
17
Steroids in intractable childhood epilepsy: Clinical experience and review of the literature by Helene Verhelst, Paul Boon, Gunnar Buyse, Berten Ceulemans, Marc D’Hooghe, Linda De Meırleır, Danièle Hasaerts, Anna Jansen, Lieven Lagae, Alfred Meurs, Rudy Van Coster, Kristl Vonck
Published 2005Artigo -
18
<i>SCN1B</i>‐linked early infantile developmental and epileptic encephalopathy by Alec Aeby, Claudine Sculier, Alexandra A. Bouza, Brandon Askar, Damien Lederer, Anne‐Sofie Schoonjans, Marc Vander Ghinst, Berten Ceulemans, James Offord, Luis F. Lopez‐Santiago, Lori L. Isom
Published 2019Artigo -
19
A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome by Andrew Ligsay, Anke Van Dijck, Danh V. Nguyen, Reymundo Lozano, Yanjun Chen, Erika Bickel, David Hessl, Andrea Schneider, Kathleen Angkustsiri, Flora Tassone, Berten Ceulemans, R. Frank Kooy, Randi J. Hagerman
Published 2017Artigo -
20
Impact of fenfluramine on the expected SUDEP mortality rates in patients with Dravet syndrome by J. Helen Cross, Bradley S. Galer, António Gil‐Nagel, Orrin Devinsky, Berten Ceulemans, Lieven Lagae, An‐Sofie Schoonjans, Elizabeth Donner, Elaine Wirrell, Sanjeev V. Kothare, Anupam Agarwal, Michael Lock, Arnold R. Gammaitoni
Published 2021Artigo
Search Tools:
Related Subjects
Medicine
Epilepsy
Psychiatry
Internal medicine
Biology
Genetics
Gene
Pediatrics
Anesthesia
Dravet syndrome
Fenfluramine
Neuroscience
Receptor
Serotonin
Phenotype
Adverse effect
Psychology
Mutation
Pathology
Surgery
Missense mutation
Physics
Alternative medicine
Electroencephalography
Encephalopathy
Epilepsy syndromes
Immunology
Placebo
Randomized controlled trial
Tolerability